STUDY TO EVALUATE THE EFFECT OF PF-06882961 ON SINGLE DOSE ATORVASTATIN, MEDAZOLAM AND ORALCONTRACEPTIVE PHARMACOKINETICS IN HEALTHY ADULT PARTICIPANTS
Clinical trial NCT05093205 · COMPLETED
Trial details
- NCT number
- NCT05093205
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-25
- Primary completion
- 2022-07-06
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.